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Objective: To determine the effects of dietary-induced weight loss (D) and weight loss plus exercise
(D þ E) compared to exercise alone (E) on bone mineral density (BMD) in older adults with knee
osteoarthritis (OA).
Design: Data come from 284 older (66.0  6.2 years), overweight/obese (body mass index (BMI)
33.4  3.7 kg/m2), adults with knee OA enrolled in the Intensive Diet and Exercise for Arthritis (IDEA)
study. Participants were randomized to 18 months of walking and strength training (E; n ¼ 95), dietary-
induced weight loss targeting 10% of baseline weight (D; n ¼ 88) or a combination of the two (D þ E;
n ¼ 101). Body weight and composition (DXA), regional BMD, were obtained at baseline and 18 months.
Results: E, D, and D þ E groups lost 1.3  4.5 kg, 9.1  8.6 kg and 10.4  8.0 kg, respectively (P < 0.01).
Signiﬁcant treatment effects were observed for BMD in both hip and femoral neck regions, with the D
and D þ E groups showing similar relative losses compared to E (both P < 0.01). Despite reduced BMD,
fewer overall participants had T-scores indicative of osteoporosis after intervention (9 at 18 months vs 10
at baseline). Within the D and D þ E groups, changes in hip and femoral neck, but not spine, BMD
correlated positively with changes in body weight (r ¼ 0.21 and 0.54 respectively, both P  0.01).
Conclusions: Weight loss via an intensive dietary intervention, with or without exercise, results in bone
loss at the hip and femoral neck in overweight and obese, older adults with OA. Although the exercise
intervention did not attenuate weight loss-associated reductions in BMD, classiﬁcation of osteoporosis
and osteopenia remained unchanged.
Clinical trial registration number: NCT00381290.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a leading cause of disability in older
adults1, with obesity recognized as the strongest modiﬁable riskD.P. Beavers, Department of
e, Winston-Salem, NC 27157,
(D.P. Beavers), kbeavers@
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r).
ternational. Published by Elsevier Lfactor for the condition. Even modest weight loss (i.e., 5% of
baseline weight) substantially improves physical function in this
population2,3. Nonetheless, concern exists about weight loss-
associated reductions in lean and bone mass4,5, and the potential
for exacerbation of age-related risk of disability6,7 and osteopo-
rotic fracture8,9. Regarding the latter, although patients with
obesity and OA typically present with high bone mineral density
(BMD)10, paradoxically, they may be at increased risk of fracture11e
13. Sustained fractures, especially at the hip, compromise quality
and expectancy of life14,15; thus, identiﬁcation of adjuvants to
weight loss that minimize bone loss in obese, older adults with OA
is warranted16.td. All rights reserved.
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during weight loss, including behavioral interventions. Several
studies show a positive effect of exercise training on BMD inweight
stable, older adults17,18, and it may be an effective means to prevent
bone loss during weight loss. Some, but not all19e21, studies show
that performing regular weight-bearing (e.g., walking) and/or
muscular loading (e.g., resistance) exercise may preserve bone
during weight loss22e25. Results of these studies, however, are
highly variable and may not be generalizable to older adults with
chronic conditions that limit exercise capacity, such as OA.
Whether exercise can prevent weight loss-associated bone loss
in older, obese adults with OA is not yet known. Therefore, the pri-
mary purpose of this study is to begin to determine the effects of
dietary-induced weight loss plus walking and strength training ex-
ercise (D þ E) compared to dietary-induced weight loss (D) and
exercise (E) alone on regional BMD and T-scores at the hip and spine
in a subset of overweight and obese, older adults with OA partici-
pating in the Intensive Diet and Exercise for Arthritis (IDEA) study.
Secondarily, we describe the relationships between change in BMD
and change in body weight, composition, and adiposity in the
treatment arms undergoing intentional weight loss (D þ E and D).
Methods
Study design and participants
Participants included in the present analysis were enrolled in
the IDEA study, a single-blinded, randomized, controlled trial (RCT)
designed to determine whether signiﬁcant weight loss (i.e., 10%
reduction in bodyweight induced by diet, with or without exercise)
improves mechanistic (knee joint loads and inﬂammation) and
clinical (pain, function, mobility, and health-related quality of life)
outcomes more than exercise alone in overweight and obese, older
adults with knee OA3,26. A total of 454 participants were originally
randomized (using a computer based permuted random block
design, within bodymass index (BMI) and gender subgroups) to 18-
months of E, D, or D þ E, a subset of which consented to baseline,
DXA-acquired, areal BMD measurement of the hip and lumbarFig. 1. IDEA bone cospine (n ¼ 129, 128 and 135 for E, D, and D þ E groups at baseline,
respectively). All participants were offered DXA scans, but partici-
pants were allowed to refuse due to concerns about radiation
exposure or schedule conﬂicts. Participants were lost to follow up
during the trial due to study attrition (n ¼ 108), and missing data
are assumed missing at random. The present analysis utilizes only
the participants in whom we obtained a baseline and 18-month
DXA scan (n ¼ 284, see Fig. 1).
Individuals were eligible to participate in the IDEA study if they
were ambulatory, community-dwelling, sedentary (30 min/week
of formal exercise within the past 6 months), overweight or obese
(27.0  BMI  40.1 kg/m2), older (55 years) adults who had grade
IIeIII (mild to moderate) radiographic tibiofemoral OA or tibiofe-
moral plus patellofemoral OA of one or both knees. TheWake Forest
University institutional review board approved the study, all par-
ticipants signed an informed consent, and the primary outcome
paper has been published3.
Intensive dietary-induced weight loss intervention
Both the D and D þ E groups received the same dietary inter-
vention, with an average weight loss goal of 10e15% of baseline
weight. The dietary plan was based on partial meal replacements,
including up to two meal-replacement shakes per day (General
Nutrition Centers, Inc., Pittsburgh, PA.), with each shake providing
500 mg of calcium. For the third meal, participants followed a
weekly menu plan and recipes that were low in fat, and high in
vegetables, and provided 500e750 kcals/day. Collectively, the diet
plan provided an energy-intake deﬁcit of 800e1000 kcals/day, as
predicted by resting energy expenditure (estimated resting
metabolism  1.2 activity factor), with 15e20% of calories coming
from protein, <30% from fat, and 45e60% from carbohydrate.
Body weight was monitored in weekly nutrition and behavior
education sessions. Individuals trained in behavioral therapy and
experienced in working with older adults ran all group and indi-
vidual sessions, with one individual session and three group ses-
sions per month for the ﬁrst 6 months. Behavioral session topics
included problem solving, goal-setting, review of a speciﬁc foodnsort diagram.
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prepared with easily available ingredients. From months seven to
18, participants attended biweekly group behavioral sessions, with
an individual appointment every 2 months.
Exercise intervention
The Dþ E and E groups received the same exercise intervention,
which consisted of overground walking (15 min), strength training
(20min), a second walking phase (15min), and cool-down (10min)
3 days per week for 18 months. During the ﬁrst 6 months, partic-
ipation was center-based. After the initial 6-months, participants
could remain in the facility program, opt for a home-based pro-
gram, or combine the two. Further details of the interventions used
in all treatment arms can be found in the IDEA design and rationale
paper26.
Body composition and clinical classiﬁcation of BMD
All outcome measures were assessed by blinded study staff.
Participant height and body mass were assessed at baseline and 18
months. Height was measured using a stadiometer and body mass
was measured on a calibrated electronic scale. BMI was calculated
as body mass in kg divided by height in meters squared. Total body
fat and lean mass, and regional BMD were assessed using dual-
energy X-ray absorptiometry (DXA, Hologic Delphi A 11.0 QDR,
Bedford, MA) at baseline and 18 months. Speciﬁcally, bone density
(BMD; g/cm2) was measured at the posterior anterior lumbar spine
(L1-L4) and hip (femoral neck, trochanter, and intertrochanter
space). DXA measurements were made by a certiﬁed technician
blinded to treatment arm and the manufacturer’s recommenda-
tions for patient positioning, scanning, and analysis scans were
followed. Osteoporosis and osteopenia were deﬁned as location-
speciﬁc T-scores 2.5 and between 2.5 and 1, respectively27.
Covariate measurements
Baseline covariate assessments included self-reported de-
mographic, medical history, and co-morbidity information. Pre-
scription bone medication usage and calcium/vitamin D
supplementation were also captured via self-report at baseline.
Serum leptin
Serum leptin concentration was measured as a biomarker of
adiposity and a potential mediator of the adiposity-BMD associa-
tion28. Blood draws were performed on a subsample of participants
(n ¼ 116) in the fasted state at baseline and 18-months and tested
using a commercial radioimmunoassay (Millipore, Billerica, MA).
The subsample consisted of participants that consented to addi-
tional MRI and CT scans, who were selected as a random sample
from the latter waves of study recruitment.
Statistical analysis
Descriptive statistics were summarized by intervention group at
baseline using means  standard deviations or frequencies and
percentages. The overall intervention effect on change in regional
BMD was estimated using one-way ANOVA (unadjusted results)
and analysis of covariance (ANCOVA, adjusted results), with results
presented as means and 95% conﬁdence intervals. The ANCOVA
model testing the intervention effect included adjustment for
gender, baseline BMI and baseline regional BMD value in accor-
dance with the IDEA trial analytic plan26 to accommodate study
stratiﬁcation factors and to ensure that the variance is not biased.To ensure ﬁndings were not affected by bone medication and
supplement use, additional ANCOVA models (as previously
described) were performed, further adjusting for prescription bone
medication use or calcium/vitamin D supplementation.
Associations between intentional weight (and body composi-
tion) loss and change in BMD from baseline were assessed in D and
D þ E arms, only. Pearson correlations were generated to measure
the strength of the association between percentage changes in
body weight and changes in regional BMD. Eighteen month change
in regional BMD per kg change in body mass and composition or
per ng/mL change in leptin was modeled using linear regression,
adjusting for randomization arm, gender, baseline BMI, and base-
line outcome measure. Because leptin is often considered a global
adiposity biomarker, the previous association between leptin and
percent BMD change was further adjusted for change in total fat
mass. Lastly, to aid in clinical interpretability and detect a potential
nonlinear associations between BMD and weight change, associa-
tions between change in regional BMD by overall percent weight
change were modeled using ANCOVA with percent weight change
tertile as the independent variable, adjusted for randomization
arm, gender, baseline BMI, and baseline regional BMD.
SAS software (version 9.3, SAS Institute Inc, Cary, NC) was used
for all analyses, with a Type I error rate of 0.05 for overall group
comparisons and associations. Pairwise comparisons of treatment
arms were deemed signiﬁcant at a Bonferroni-adjusted Type I error
rate of 0.0167, as prescribed in the IDEA analytic plan26.
Results
Baseline characteristics
Recruitment and retention characteristics of the present anal-
ysis are presented in Fig. 1. Baseline DXA measurements were
performed on 392 of the 454 IDEA trial participants, and 284 par-
ticipants who had a baseline DXA scan returned for an 18-month
visit scan. Race was the only signiﬁcant predictor of DXA study
attrition, with AfricaneAmerican participants more likely to with-
draw (41.2%) than white participants (26.5%, P ¼ 0.02). Baseline
demographic data on the IDEA study sample used in this analysis
(n ¼ 284) are presented by treatment arm in Table I. Overall, par-
ticipants were 66.0  6.2 years of age with an average BMI of
33.4  3.7 kg/m2. Women represented 74% of the study sample and
86% self-identiﬁed as Caucasian, similar to the total IDEA sample3.
Although only 9% of participants self-reported a prior diagnosis of
osteoporosis, reported use of bone prescription medication was
25%, and reported use of calcium and vitamin D supplementation
was 51%. Based on DXA-acquired BMD and calculated T-scores, 179
(47%) participants were classiﬁed as osteopenic and 15 (4%) par-
ticipants were classiﬁed as osteoporotic at baseline.
Intervention effect on BMD and clinical classiﬁcation
Over the 18-month intervention period an average of
9.1  8.6 kg (9.7  8.5%) and 10.4  8.0 kg (11.3  8.3%) of initial
body weight was lost in the D and D þ E arms, respectively (both
P < 0.01), with a minimal but signiﬁcant loss in body weight
observed in the E-only group (1.3  4.5 kg, 1.4  4.6%; P < 0.01).
Mean diet session attendance for D (67.8  17.8%) and D þ E groups
(68.7 19.7%) did not signiﬁcantly differ (P¼ 0.75); likewise, mean
exercise session attendance did not differ by group (E¼ 61.121.6%
and D þ E ¼ 63.2  20.9; P ¼ 0.49).
Unadjusted and adjusted 18-month treatment effects on BMD
are presented in Table II. Signiﬁcant treatment effects were
observed for both hip and femoral neck regions, with the D and
D þ E groups showing signiﬁcant absolute and relative losses in
Table I
Baseline descriptive characteristics according to treatment group for individuals
with baseline and follow-up DXA data
Participant characteristics Exercise (n ¼ 95) Diet (n ¼ 88) Diet þ Exercise
(n ¼ 101)
Age (years) 65.8  6.3 66.0  6.0 66.1  6.4
Female, n (%) 71 (75) 61 (70) 77 (76)
White, n (%) 80 (84) 79 (90) 85 (84)
Weight (kg) 91.6  13.5 91.8  15.0 91.4  14.1
BMI (kg/m2) 33.5  3.7 33.2  3.6 33.4  3.7
Total body fat mass (kg) 36.6  7.9 36.5  7.1 36.3  8.5
Total body lean mass (kg) 55.5  11.5 55.1  12.4 54.6  10.9
Leptin (ng/mL)* 40.8  20.5 36.6  22.4 37.8  28.5
Self-reported osteoporosis 6 (6) 9 (11) 9 (9)
Self-reported bone
medication usey
24 (25) 18 (20) 28 (28)
Self-reported
calcium/vitamin D use
55 (58) 40 (45) 49 (49)
Areal BMD
Hip BMD (mg/cm2) 968  135 981  162 962  120
Femoral neck BMD
(mg/cm2)
792  109 805  124 791  109
Spine BMD (mg/cm2) 1070  176 1080  199 1070  161
T-score
Hip 0.02  0.95 0.05  1.11 0.02  0.88
Femoral neck 0.66  0.88 0.59  1.00 0.66  0.91
Spine 0.13  1.54 0.17  1.71 0.10  1.39
DXA-derived
osteoporosisz, n (%)
2 (2) 5 (6) 3 (3)
DXA-derived
osteopeniaz, n (%)
50 (53) 44 (44) 39 (44)
Data are presented as means  SD or n (%). Abbreviations: n ¼ sample size;
kg ¼ kilogram; m ¼ meter; g ¼ gram; cm ¼ centimeter; DXA ¼ dual-energy X-ray
absorptiometry.
* Leptin total subsample with BL and 18-month measures: n ¼ 116 (E: n ¼ 39; D:
n ¼ 36; D þ E: n ¼ 41).
y Queried bone medications include Actonel, Fosamax, Boniva, and Forteo.
z Baseline osteoporosis and osteopenia classiﬁcations were based on a DXA-
acquired BMD T-score  2.5 or 2.5<T-score < 1 at the hip, femoral neck or
spine, respectively.
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BMDmeasurements did not signiﬁcantly differ from baseline in the
E-only group, it is worth noting that estimates were negative. Re-
sults were largely unchanged after adjustment for gender, baseline
BMI, and baseline regional BMD value. No treatment effect was
observed for spine BMD. Further analyses adjusting for baseline
prescription bone medication use or calcium/vitamin D supple-
mentation did not modify the observed treatment effects (data not
shown).
Ten participants with baseline and follow-up DXA-derived T-
score values were classiﬁed as osteoporotic (one hip, three
femoral neck, and six spine) and 46.8% (133) had osteopenia in atTable II
Unadjusted and adjusted treatment effects on change in BMD by region
Change in BMD by region Exercise (n ¼ 95) Diet (n ¼ 88)
Mean (95% CI) % Chg Mean (95% CI)
D Total hip BMD (mg/cm2)
Unadjusted 2.1 (8.2, 4.0) 0.2 24.0 (30.3, 1
Adjusted 2.0 (8.5, 4.4) 0.2 23.7 (30.3, 1
D Femoral neck BMD (mg/cm2)
Unadjusted 2.6 (8.2, 2.9) 0.3 15.3 (21.0, 9
Adjusted 0.8 (6.6, 5.0) 0.1 13.2 (19.1, 7
D Spine BMD (mg/cm2)
Unadjusted 5.2 (2.1, 12.4) 0.5 3.5 (4.0, 11.0
Adjusted 7.5 (0.2, 15.1) 0.7 5.4 (2.4, 13.2
Unadjusted estimates are based on a one-way ANOVA at 18 months. Model-adjusted esti
BMD ¼ areal bone mineral density; n ¼ sample size; SE ¼ standard error.
*P-value at 18 months performed based on test from a contrast statement to compare g
**E differs signiﬁcantly from D and D þ E (P < 0.01).least one site at baseline. Following intervention, nine partici-
pants had T-scores indicative of osteoporosis in any region and
49.3% (140) had osteopenia. Only one participant (D group)
progressed from osteopenia to osteoporosis while two partici-
pants (one E and one D) classiﬁed as osteoporotic at baseline
changed to osteopenia at 18 months. Eleven participants (2 E, 3
D, 6 D þ E) progressed from normal BMD to osteopenia in at least
one region at 18 months.Associations between measures of body weight, composition, and
adiposity and regional BMD change
To assess the independent contribution of the magnitude of
intentional weight loss on change in percent BMD, the E-only group
was removed from the following analyses, and D and D þ E group
were combined (see Table III). For D and D þ E groups, changes in
femoral neck and hip BMD correlated positively with changes in
body weight (r ¼ 0.21 and 0.54, both P  0.01). Model-adjusted
estimates controlling for randomization group, gender, baseline
BMI, and baseline outcome measures revealed a 1 kg loss in body
weight was associated with a 0.10  0.03% reduction in femoral
neck BMD and a 0.20 0.03% reduction in hip BMD.While changes
in both fat mass and lean mass were signiﬁcantly associated with
percent change in hip BMD, only fat mass changes were associated
with change in femoral neck BMD.
The relationship between change in bone density and body
weight and compositionwas also modeled by comparing change in
regional BMD by tertile of percentage weight loss for the D and
D þ E groups only (Table IV, no interaction was found between
randomization group and tertile of weight loss). Participants
experiencing the greatest weight loss (12.9%) showed markedly
greater reductions of BMD at the femoral neck and hip, but not the
spine, compared to participants in the lowest tertile of weight loss
(<5.2%). Similar results were observed when losses of fat and lean
mass were considered (data not shown).
Lastly, as a potential mediator of the association between
change in fat and bone mass, associations between change in
regional bone mass and change in serum leptin were assessed.
Unadjusted associations, shown in Fig. 2(a)e(c), suggest a direct
relationship, with a stronger linear association between change in
leptin and change in hip BMD (r ¼ 0.43, P < 0.01) and between
leptin change and femoral neck change (r ¼ 0.41, P < 0.01) when
compared to spine BMD change and leptin change (r ¼ 0.10,
P ¼ 0.09). Model-adjusted change in leptin was signiﬁcantly asso-
ciated with change in BMD for each location, although all associa-
tions became nonsigniﬁcant after further adjustment for total body
fat mass (see Table III).Diet þ Exercise (n ¼ 101) Overall P-value*
% Chg Mean (95% CI) % Chg
7.6) 2.5 19.4 (25.3, 13.5) 2.0 <0.01**
7.2) 2.4 19.5 (25.8, 13.2) 2.0 <0.01**
.5) 1.9 14.4 (19.8, 9.1) 1.8 <0.01**
.3) 1.7 12.5 (18.1, 6.8) 1.6 <0.01**
) 0.3 0.9 (7.9, 6.1) 0.1 0.47
) 0.5 1.5 (6.0, 9.0) 0.1 0.50
mates control for gender, baseline BMI and baseline risk factor value. Abbreviations:
roups.
Table III
18-month changes in BMD from baseline per unit change in measures of body composition and leptin, D and D þ E arms only
Change in body weight and composition D Total hip BMD (mg/cm2) D Femoral neck BMD (mg/cm2) D Spine BMD (mg/cm2)
b (95% CI) P-value b (95% CI) P-value b (95% CI) P-value
D Total body weight (kg) 1.9 (1.5, 2.4) <0.01 0.8 (0.3, 1.3) <0.01 0.4 (0.3, 1.01) 0.19
D Total body lean mass (kg) 3.8 (2.3, 5.4) <0.01 1.4 (0.0, 2.8) 0.06 0.00 (1.8, 1.8) 0.99
D Total body fat mass (kg) 2.8 (2.1, 3.4) <0.01 1.2 (0.5, 1.8) <0.01 0.8 (0.0, 1.66) 0.06
D Leptin (ng/dL)* 1.2 (0.7, 1.7) <0.01 0.7 (0.3, 1.0) <0.01 0.6 (0.0, 1.1) 0.04
D Leptin (ng/dL), further adjusted for fat mass change** 0.3 (0.2, 0.8) 0.26 0.4 (0.0, 0.8) 0.05 0.5 (0.2, 1.2) 0.14
Model estimates adjust for randomization group, gender, baseline BMI, and baseline location BMD value.
* Statistical signiﬁcance (P < 0.05) unchanged using log-leptin in model in place of leptin except for spine (log-leptin P ¼ 0.16).
** Nonsigniﬁcance (P  0.05) unchanged using log-leptin in place of leptin.
Table IV
Change in bone mineral density by tertile* of percentage weight loss, D and D þ E arms only
Change in BMD by region Tertile 1 (n ¼ 72) Tertile 2 (n ¼ 73) Tertile 3 (n ¼ 72) Overall P-value*
Mean (95% CI) Mean (95% CI) Mean (95% CI)
D Total hip BMD (mg/cm2) 5.0 (12.9, 2.9) 18.5 (25.8, 11.2) 36.6 (43.7, 29.5) <0.01
D Femoral neck BMD (mg/cm2) 6.2 (13.7, 1.3) 8.0 (14.9, 1.1) 21.5 (28.2, 14.8) <0.01
D Spine BMD (mg/cm2) 10.1 (4.0, 21.1) 6.8 (5.7, 19.3) 1.7 (13.6, 10.2) 0.37
All tertiles for total hip achieve pairwise statistical signiﬁcance (P< 0.0167). Additionally, tertile 3 compared to tertiles 1 and 2 for femoral neck achieves pairwise signiﬁcance.
Model estimates adjusted for randomization arm, gender, baseline BMI, and baseline regional BMD.
* Where Tertile 1 experienced <5.18% weight loss, Tertile 2 experienced  5.18% but <12.86% weight loss and Tertile 3 experienced 12.86% weight loss.
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Fig. 2. a. Linear association between hip BMD changes and leptin changes. b. Linear association between femoral neck BMD changes and leptin changes. c. Linear association
between spine BMD changes and leptin changes.
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Results from this exploratory study provide novel information
about the independent and combined effects of intensive dietary-
induced weight loss and exercise training on regional BMD in
overweight and obese, older adults with knee OA. We report that
10% weight loss occurring over 18-months, with or without exer-
cise, is associated with signiﬁcant reductions in hip and femoral
neck, but not spine, BMD. Participants who lost the most weight
and fat mass also lost the most hip and femoral neck BMD,
regardless of baseline BMI, BMD, or exercise status. However,
despite signiﬁcant BMD loss, clinical classiﬁcation of osteoporosis
and osteopenia remained virtually unchanged.
The addition of exercise to dietary-induced weight loss is hy-
pothesized to attenuate the loss of BMD associatedwith weight loss
by countering reductions in mechanical stress29. Indeed, exercise in
the absence of weight loss is consistently shown to have a positive
effect on BMD in older adults17,18. To date, however, only four RCTs
(including the present study) have been designed to examine the
additive effect of exercise training to dietary-induced weight loss
on BMD in older adults, with conﬂicting results reported. The ﬁrst
study, conducted in 1993 by Svendsen and colleagues19, enrolled
118 overweight postmenopausal women to participate in a 3-arm
(control, diet, and diet plus combined aerobic/non-aerobic exer-
cise) 12-week RCT. Despite signiﬁcant weight loss achieved in the
diet groups compared to control, no consistent, major group dif-
ferences in total body, spinal, or forearm BMD were observed19.
These seminal ﬁndings suggest that the addition of exercise to
weight loss does not prevent bone loss, although the short duration
of this study intervention likely compromised the ability to observe
signiﬁcant changes in bone remodeling between treatment arms30.
In contrast, two recent, longer RCTs suggest that exercise (high
intensity resistance training23 or a combined aerobic and resistance
training program25) is effective for maintaining total body23 and
regional25 bone mass in overweight and obese older adults un-
dergoing intentional weight loss.
The study design and outcomes assessed by Shah et al.25 most
closely resemble the current study and, given discordant results, it
is of interest to speculatewhich study characteristics contributed to
the conﬂicting ﬁndings. Although total weight loss achieved in diet
groups and exercise modality/frequency were similar between the
studies, differences were noted in exercise duration (90 min/day25
vs 60min/day in the present study) and adherence (83%25 vs 63% in
our study, in combined diet and exercise groups). Importantly, and
in contrast to our ﬁndings, the exercise intervention utilized by
Shah et al.25 increased hip BMD in the exercise-only group over
time, suggesting that increased compliance to exercise pre-
scriptions of longer duration may signiﬁcantly inﬂuence change in
BMD. That being said, the time course of the two studies was
different (12 months25 vs 18 months in our study), and a true cross-
study comparison requires consideration of normal age-related
bone loss (i.e., w1% per year)31e33. Thus, participants in the IDEA
study would have been expected to lose greater amounts of BMD
simply due to the longer duration of the study, which may or may
not be mitigated by exercise training. Finally, although both studies
sampled overweight and obese, older adults with functional limi-
tations (mild-to-moderate frailty25 vs OA in the present study),
persons with OA have unique risks for fracture11,12 and compro-
mised exercise ability34, which require separate characterization.
Findings from Shah et al.25 and other RCTs of exercise may not be
applicable to this population, as the total exercise dose realistically
achievable by persons with OA may not be sufﬁcient to prevent
age- and weight loss-associated BMD loss.
Findings presented here examining the magnitude of BMD loss-
associated with weight loss are in line with other weight loss trialsreporting a 1e2% reduction in regional BMD associated with a 10%
loss in baseline weight5. Results also concur with prior literature in
older adults showing that when diet and exercise groups are
compared to a weight stable group, weight loss is consistently
associated with reduced BMD19,21,25 and that changes in fat mass
are directly correlated to changes in bone mass35,36. Leptin data
presented here lend support to the hypothesis that weight loss-
induced reductions in leptin could belie the association between
weight loss and bone loss28; however, it is worth noting that this
relationship did not hold after further adjustment for fat mass
change, which has been shown before37.
Clinically, weight loss-associated loss in BMD is concerning due
to the well-known association between low BMD and fracture
risk9,38. Indeed, BMD is a strong predictor of future osteoporotic
fracture39, and observational data consistently link weight loss in
late life with loss of BMD8,9; yet, whether the magnitude of BMD
loss observed in this study translates into increased fracture risk
remains unknown. Encouragingly, clinical classiﬁcation of osteo-
porosis and osteopenia was unchanged in IDEA participants un-
dergoing weight loss. Moreover, although the exercise prescription
utilized in IDEA did not prevent reductions in BMD, fracture risk
assessment is multifactorial and overall risk may be reduced due to
parallel improvements in pain and function attributable to the
study intervention3.
Strengths of the present study include the RCT design, large
sample size and serial measures of BMD at clinically important sites
of osteoporotic fracture. This study is not without limitations,
however. First, the main IDEA trial was conceived and executed to
explore the effect of E, D, and D þ E on IL-6 and knee compressive
forces26; thus, the present analysis is an exploratory investigation
of the effect of body composition changes on BMDwithin a random
subgroup of the IDEA trial. Because this speciﬁc analytic plan and
study power were not determined a priori at the time of the trial’s
inception, ﬁndings should be considered hypothesis-generating
rather than conﬁrmatory. Second, although DXA-acquired areal
BMD is the primary metric by which osteoporosis is assessed, it is
insufﬁcient to quantify future fracture risk40, and presents a num-
ber of methodological limitations in the context of obesity and
weight loss41,42. Future studies evaluating intervention effective-
ness on skeletal health would be strengthened by the integration of
measures of bone quality43, such as volumetric BMD, thickness and
strength estimates, which should improve fracture risk predictive
power. Third, the age and proclivity of our study population to
develop osteophytes44 may have inﬂuenced BMD measures, and
results may not be generalizable to older adults without OA.
Additionally, the possibility that overweight and obese adults
develop leptin resistance raise questions about whether our sample
is appropriate for studying any leptin-bone association45. Lastly, the
protective effect of calcium supplementation5 osteoporosis medi-
cations on BMD during weight loss is strong46 and, although sta-
tistical adjustment for calcium/vitamin D intake or medication use
did not affect study results, the protective effect of pharmaco-
therapy on BMD may have compromised our ability to observe
lifestyle-based differences.
In summary, 18-months of intensive dietary-induced weight
loss, with or without exercise training, in overweight and obese
older adults with OA results in bone loss at the hip and proximal
femur. Although the exercise intervention did not attenuate weight
loss-associated reductions in BMD, clinical classiﬁcation of osteo-
porosis and osteopenia in the population remained unchanged.
Future intervention studies seeking to evaluate and minimize the
risk/beneﬁt ratio associated with weight loss in overweight and
obese older adults need to include osteoporosis-related fractures as
an endpoint. Further, additional clariﬁcation as to the duration,
intensity, and type of exercise necessary to minimize bone loss in
D.P. Beavers et al. / Osteoarthritis and Cartilage 22 (2014) 726e733732older adults undergoing intentional weight loss e including those
with disease speciﬁc conditions, such as OA, that are often ignored
e is needed from well-designed RCTs.
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